...
首页> 外文期刊>Preparative biochemistry & biotechnology: An international journal for rapid communication >Production, Purification, and Antibiofilm Activity of a Novel Exopolysaccharide from Arthrobacter sp. B4
【24h】

Production, Purification, and Antibiofilm Activity of a Novel Exopolysaccharide from Arthrobacter sp. B4

机译:关节杆菌属一种新型胞外多糖的生产,纯化和抗生物膜活性B4

获取原文
获取原文并翻译 | 示例

摘要

A novel exopolysaccharide (EPS), namely, B4-EPS, is produced by Arthrobacter sp. B4. Response surface methodology (RSM) was employed to optimize the fermentation medium for increasing B4-EPS production. Based on Plackett-Burman design (PBD), glucose, yeast extract, and KH_(2)PO_(4) were selected as significant variables, which were further optimized by a central composite design (CCD). According to response surface and canonical analysis, the optimal medium was composed of 16.94 g/L glucose, 2.33g/L yeast extract, and 5.32 g/L KH_(2)PO_(4). Under this condition, the maximum yield of B4-EPS reached about 8.54 g/L after 72 hr of batch fermentation, which was pretty close to the predicted value (8.52 g/L). Furthermore, B4-EPS was refined by column chromatography. The main homogeneous fraction (B4-EPS1) was collected and applied to assay of antibiofilm activity. B4-EPS1 exhibited a dose-dependent inhibitory effect on biofilm formation of Pseudomonas aeruginosa PAO1 without antibacterial activity. About 86.1% of biofilm formation of P. aeruginosa PAO1 was inhibited in the presence of 50 μg=mL B4-EPS1, which was more effective than the peer published data. Moreover, B4-EPS1 could prevent biofilm formation of other strains. These data suggest B4-EPS may represent a promising strategy to combat bacterial biofilms in the future.
机译:一种新型的胞外多糖(EPS),即B4-EPS,是由节杆菌属细菌生产的。 B4。响应面法(RSM)用于优化发酵培养基以增加B4-EPS产量。根据Plackett-Burman设计(PBD),选择了葡萄糖,酵母提取物和KH_(2)PO_(4)作为重要变量,并通过中央复合设计(CCD)对其进行了进一步优化。根据反应面和典型分析,最佳培养基由16.94 g / L葡萄糖,2.33g / L酵母提取物和5.32 g / L KH_(2)PO_(4)组成。在此条件下,分批发酵72小时后,B4-EPS的最大产量达到约8.54 g / L,非常接近预测值(8.52 g / L)。此外,通过柱色谱法精制B4-EPS。收集主要的均相馏分(B4-EPS1)并用于抗生物膜活性的测定。 B4-EPS1对铜绿假单胞菌PAO1的生物膜形成表现出剂量依赖性的抑制作用,而没有抗菌活性。在50μg= mL B4-EPS1的存在下,约有86.1%的铜绿假单胞菌PAO1生物膜形成受到抑制,这比同行发表的数据更为有效。此外,B4-EPS1可以防止其他菌株的生物膜形成。这些数据表明,B4-EPS可能代表未来对抗细菌生物膜的一种有前途的策略。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号